Cue Biopharma Inc.

0.80
-0.04 (-4.34%)
At close: Apr 24, 2025, 11:09 AM

Cue Biopharma Statistics

Share Statistics

Cue Biopharma has 75.35M shares outstanding. The number of shares has increased by 30.23% in one year.

Shares Outstanding 75.35M
Shares Change (YoY) 30.23%
Shares Change (QoQ) 0%
Owned by Institutions (%) 22.95%
Shares Floating 74.78M
Failed to Deliver (FTD) Shares 600
FTD / Avg. Volume 0.31%

Short Selling Information

The latest short interest is 851.92K, so 1.34% of the outstanding shares have been sold short.

Short Interest 851.92K
Short % of Shares Out 1.34%
Short % of Float 1.35%
Short Ratio (days to cover) 9.37

Valuation Ratios

The PE ratio is -1.51 and the forward PE ratio is -1.9. Cue Biopharma's PEG ratio is 0.04.

PE Ratio -1.51
Forward PE -1.9
PS Ratio 6.61
Forward PS 1.3
PB Ratio 3.51
P/FCF Ratio -1.69
PEG Ratio 0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Cue Biopharma.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.51.

Current Ratio 1.84
Quick Ratio 1.84
Debt / Equity 0.51
Debt / EBITDA -0.21
Debt / FCF -0.24
Interest Coverage -52.14

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $226.51K
Profits Per Employee $-992.05K
Employee Count 41
Asset Turnover 0.29
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -40.85% in the last 52 weeks. The beta is 2.03, so Cue Biopharma's price volatility has been higher than the market average.

Beta 2.03
52-Week Price Change -40.85%
50-Day Moving Average 1.01
200-Day Moving Average 1.04
Relative Strength Index (RSI) 48.42
Average Volume (20 Days) 193.07K

Income Statement

In the last 12 months, Cue Biopharma had revenue of 9.29M and earned -40.67M in profits. Earnings per share was -0.72.

Revenue 9.29M
Gross Profit 9.29M
Operating Income -41.5M
Net Income -40.67M
EBITDA -41.5M
EBIT -41.47M
Earnings Per Share (EPS) -0.72
Full Income Statement

Balance Sheet

The company has 22.46M in cash and 8.88M in debt, giving a net cash position of 13.58M.

Cash & Cash Equivalents 22.46M
Total Debt 8.88M
Net Cash 13.58M
Retained Earnings -341.86M
Total Assets 32.19M
Working Capital 11.45M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -36.33M and capital expenditures -66K, giving a free cash flow of -36.4M.

Operating Cash Flow -36.33M
Capital Expenditures -66K
Free Cash Flow -36.4M
FCF Per Share -0.65
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -446.86% and -437.97%.

Gross Margin 100%
Operating Margin -446.86%
Pretax Margin -437.97%
Profit Margin -437.97%
EBITDA Margin -446.86%
EBIT Margin -446.86%
FCF Margin -391.89%

Dividends & Yields

CUE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CUE is $2.5, which is 197.6% higher than the current price. The consensus rating is "Buy".

Price Target $2.5
Price Target Difference 197.6%
Analyst Consensus Buy
Analyst Count 4
Stock Forecasts

Scores

Altman Z-Score -15.81
Piotroski F-Score 4